Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Zero Based Budgeting Strategies For All Income Levels provide scalable approaches suitable for any earning, family size, or goal.
25,463 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Anthropic stunned markets with a Series H that values the private AI firm near $1 trillion, signaling a new era for p...
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Investors are weighing Nvidia's aggressive capital return plans against the durability of its margins and evolving to...
EU leaders consider protective tools to curb a growing China trade surplus, signaling a shift toward tariffs and quot...
A new wave of enterprise chip investments is shaking up the AI hardware landscape. This huge news broadcom stock deve...
A little-known small-cap ETF is turning heads with bold gains in 2026. This guide explains what’s driving the perform...
Anthropic’s IPO path is shaping AI headlines, but patient investors can still win by focusing on established tech gia...
Over the past year, the more expensive GDX underperformed cheaper peers, costing investors tens of dollars per thousa...
A new ElevenLabs case study shows better.com’s Betsy AI voice agent slashing origination costs by 41% in 2025 while l...
Oil approaching $100 per barrel could upend retail economics. Walmart appears best positioned to weather an energy-dr...
XRP's leverage and open interest have tumbled, but ETF funds and Ripple's expansion keep money in the ecosystem. Trad...